Provectus Pharmaceuticals's total assets for Q3 2025 were $419.90K, a decrease of -41.87% from the previous quarter. PVCT total liabilities were $6.59M for the fiscal quarter, a -0.15% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.